Display options
Cite
Sittipo P, Lobionda S, Choi K, et al. Toll-Like Receptor 2-Mediated Suppression of Colorectal Cancer Pathogenesis by Polysaccharide A From . Front Microbiol. 2018;9:1588doi: 10.3389/fmicb.2018.01588.
Sittipo, P., Lobionda, S., Choi, K., Sari, I. N., Kwon, H. Y., & Lee, Y. K. (2018). Toll-Like Receptor 2-Mediated Suppression of Colorectal Cancer Pathogenesis by Polysaccharide A From . Frontiers in microbiology, 91588. https://doi.org/10.3389/fmicb.2018.01588
Sittipo, Panida, et al. "Toll-Like Receptor 2-Mediated Suppression of Colorectal Cancer Pathogenesis by Polysaccharide A From ." Frontiers in microbiology vol. 9 (2018): 1588. doi: https://doi.org/10.3389/fmicb.2018.01588
Sittipo P, Lobionda S, Choi K, Sari IN, Kwon HY, Lee YK. Toll-Like Receptor 2-Mediated Suppression of Colorectal Cancer Pathogenesis by Polysaccharide A From . Front Microbiol. 2018 Jul 17;9:1588. doi: 10.3389/fmicb.2018.01588. eCollection 2018. PMID: 30065713; PMCID: PMC6056687.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2018 Jul 17;9:1588. doi: 10.3389/fmicb.2018.01588. eCollection 2018.

Toll-Like Receptor 2-Mediated Suppression of Colorectal Cancer Pathogenesis by Polysaccharide A From .

Frontiers in microbiology

Panida Sittipo, Stefani Lobionda, Kyungchul Choi, Ita Novita Sari, Hyog Young Kwon, Yun Kyung Lee

Affiliations

  1. Soonchunhyang Institute of Medi-Bio Science, Soonchunhyang University, Cheonan, South Korea.

PMID: 30065713 PMCID: PMC6056687 DOI: 10.3389/fmicb.2018.01588

Abstract

The beneficial role of gut microbiota in intestinal diseases has been highlighted recently.

Keywords: Bacteroides fragilis; colorectal cancer; migration; polysaccharide A; proliferation

References

  1. Science. 1992 Dec 11;258(5089):1798-801 - PubMed
  2. J Microbiol. 2018 Mar;56(3):154-162 - PubMed
  3. J Clin Invest. 1989 Oct;84(4):1045-9 - PubMed
  4. Cell Host Microbe. 2014 Apr 9;15(4):413-23 - PubMed
  5. Cell. 2009 Nov 25;139(5):871-90 - PubMed
  6. J Clin Invest. 2009 Jun;119(6):1420-8 - PubMed
  7. Nature. 2008 May 29;453(7195):620-5 - PubMed
  8. J Immunol. 2017 Mar 1;198(5):2047-2062 - PubMed
  9. Science. 1994 Dec 16;266(5192):1821-8 - PubMed
  10. Gut. 2011 Dec;60(12):1609-10 - PubMed
  11. Cancer Treat Rev. 2007 Feb;33(1):9-23 - PubMed
  12. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  13. Nat Rev Cancer. 2017 Jan 27;17(2):93-115 - PubMed
  14. Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96 - PubMed
  15. Science. 2011 May 20;332(6032):974-7 - PubMed
  16. World J Gastroenterol. 2014 Dec 21;20(47):17699-708 - PubMed
  17. Clin Microbiol Rev. 2003 Oct;16(4):637-46 - PubMed
  18. Science. 2008 Jun 20;320(5883):1647-51 - PubMed
  19. Nat Commun. 2014 Mar 26;5:3530 - PubMed
  20. World J Gastroenterol. 2015 Nov 7;21(41):11767-76 - PubMed
  21. Asian Pac J Cancer Prev. 2013;14(5):2689-98 - PubMed
  22. Gastroenterol Rep (Oxf). 2018 Feb;6(1):1-12 - PubMed
  23. Mucosal Immunol. 2010 Sep;3(5):487-95 - PubMed
  24. J Exp Med. 2010 Aug 2;207(8):1625-36 - PubMed
  25. World J Gastroenterol. 2017 Jan 28;23(4):603-613 - PubMed
  26. PLoS One. 2010 Sep 27;5(9):e13027 - PubMed
  27. J Immunol. 2010 Oct 1;185(7):4101-8 - PubMed
  28. Cell. 2005 Jul 15;122(1):107-18 - PubMed
  29. J Biol Chem. 1992 Sep 5;267(25):18230-5 - PubMed
  30. J Interferon Cytokine Res. 1996 Jan;16(1):53-60 - PubMed
  31. Mutat Res. 2011 Jul-Oct;728(1-2):23-34 - PubMed
  32. Immunology. 1994 Jan;81(1):85-91 - PubMed
  33. CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30 - PubMed
  34. Eur J Cancer. 1968 Aug;4(4):343-66 - PubMed
  35. J Exp Med. 2006 Dec 25;203(13):2853-63 - PubMed
  36. Carcinogenesis. 1997 Apr;18(4):833-41 - PubMed

Publication Types